Quality, and Outcomes

The consensus statements that were drafted identified several needs in pharmacy Create a mission statement, develop standards for pharmacists to apply in managing pharmaceutical care, demonstrate and communicate the value of pharmaceutical care to healthcare, measure the quality and outcomes of services, strengthen political action, and convince the public and payers of the benefits of pharmaceutical care. The obstacles facing practice were also noted. The overarching conclusion was that pharmacy had to actively demonstrate and communicate its value to healthcare. 

Jobseekers are represented by local and national client councils, which together form the National Client Council (LCR). The LCR is a statutory body whose main function is to represent the views of clients to the Minister, as part of a wider tripartite consultative mechanism, the RWI. The LCR has had success in advocating individual client accounts for employment assistance (IROs) and a network of independent advisors to assist chents to locate and negotiate with a reintegration provider of their choice. The RWI is responsible for a public databank on provider quality and outcomes called the reintegration monitor . 

Mahoney, E.M., Wang, K., Keo, H.H., Duval, S., Smolderen, K.G., Cohen, D.J., Steg, G., Bhatt, D.L., Hirsch, A.T. Reduction of Atherothrombosis for Continued Health Registry I. Vascular hospitalization rates and costs in patients with peripheral artery disease in the united states. Circulation. Cardiovascular Quality and Outcomes 3, 642-651 (2010)... 

Dowrick, C., Leydon, G., McBride, A., Howe, A., Burgess, H., Clarke, P, Maisey, S. and Kendrick, T. 2009. Patients and doctors views on depression severity questionnaires incentivised in UK quality and outcomes framework Qualitative study. British MedicalJournal, 338, b663. 

Table 12.1 summarizes five major types of pharmacoeconomic evaluations cost-consequence, cost-benefit, cost-effectiveness, cost-minimization, and cost-utility (Drummond et al., 1997 Kielhorn and Graf von der Schulenburg, 2000). In a cost-consequence analysis, a comprehensive list of relevant costs and outcomes (consequences) of alternative therapeutic approaches are presented in tabular form. Costs and outcomes are typically organized according to their relationship to cost (direct and indirect), quality of life, patient preferences, and clinical outcomes (see taxonomy below). No attempt is made to combine the costs and outcomes into an economic ratio, and the interpretation of the analysis is left in large part to the reader. 

Conscious, evidence-based and outcome oriented prescribing in concordance with the patient expectation and need to improve the patient health and quality of life... 

The economic outcome of the operation of a centrally located facility is comparable with all other hydrometallurgical operations and is highly dependent on price and quality of the metals produced. All products have to conform to commercial specifications. Adequate quality and quantity of cheap feed materials are also essential. It is very important to consider the fact that the transformation of waste and raw material usually involves a dramatic increase in the value of the feed material. The economic result cannot be isolated to an auxiliary process, but is the result of the combined effects on the total operation. 

Estms cyclicity and sperm quality Pregnancy outcome, e.g., dystocia Growth, development, and viability of offspring Anogenital distance if triggered Sexual maturation... 

All the studies reviewed rely on health care or pharmaceutical spending rather than on health or pharmaceutical output as a proxy for health care received by consumers. One unintended interpretation of a positive relationship between dollars spent and outcomes would be that health care price increases alone could extend life. In reality, of course, increased spending reflects a combination of increased quantity, increased quality, and increased price of pharmaceuticals. Since these three factors cannot be separated and since pharmaceutical prices are increasing even after controlling for quality, the relationship between spending and health outcome will understate the true underlying relationship between spending and the combination of quality and quantity increases. 

One potential difficulty of cost-benefit analysis is that it requires researchers to express an intervention s costs and outcomes in the same units. Thus, monetary values must be associated with years of life lost and morbidity due to disease and with years of life gained and morbidity avoided due to intervention. Expressing costs in this way is obviously difficult in health care analyses. Outcomes (treatment benefits) may be difficult to measure in units of currency. Translating disease and treatment outcomes into monetary measures may be more difficult than translating them into clinical outcome measures, such as years of life saved or years of life saved adjusted for quality. 

The PAT guidance clearly states that industrial implementations should be risk based. Soon after the PAT team and objective have been identified, the project should commence with a formal risk assessment. The risk assessment should be focused on identifying and characterizing the failure modes which present risks to product quality the outcome of the risk assessment will provide a means prioritizing the allocation of PAT resources and a baseline for review of the effect of PAT in mitigating risks to quahty. 

Meine, T.J., M.T. Roe, A.Y. Chen, M.R. Patel, et al., Association of intravenous morphine use and outcomes in acute coronary syndromes results from the CRUSADE Quality Improvement Initiative,... 

Process characterization represents the methods used to determine the critical unit operations or processing steps and their process variables, that usually affect the quality and consistency of die product outcomes or product attributes. Process ranging represents studies that are used to identify critical process or test parameters and their respective control limits, which normally affect the quality and consistency of the product outcomes of their attributes. The following process characterization techniques may be used to designate critical unit operations in a given manufacturing process. 

Critical process steps are usually determined by analyzing process parameters (factors in a process that are controllable and measurable) and their respective outcomes. Not all process parameters affect the quality and purity of APIs namely its impurity profile and physical characteristics. For validation purposes, manufacturers should identify, control, and monitor critical process parameters that may influence the critical quality attributes of the API. Process parameters unrelated to quality, such as variables controlled to minimize energy consumption or equipment use, need not be included in process validation. 

Thus, in order to determine the processability of petroleum a series of consistent and standardized characterization procedures are required (ASTM, 1995). These procedures can be used with a wide variety of feedstocks to develop a general approach to predict processability. The ability to predict the outcome of feedstock (especially heavy oils and residua) processing offers (1) the choice of processing sequences (2) the potential for coke lay-down on the catalyst (3) determining the catalyst tolerance to different feedstocks (4) predictability of product distribution and quality and (5) incompatibility during processing and incompatibility of the products on storage. 

---